The FDA reviewed several studies regarding a link between the use of Proton Pump Inhibitors(PPI) and increased risk of fractures. Major points in review of studies:
- Use of PPIs for more than one year or at high doses patients pose risk of fractures
- Higher number of spinal fractures and not a significant change in hip fractures
- Included both prescription and non-prescription PPI medications
- Recommendations for healthcare professionals is to consider decrease dosage and duration of PPI in higher risk individuals (ie osteoporosis, ostepenias)
I recommend contacting your physician and ask how these studies may or may not effect you. All medications have side effects. Each case a risk analysis is performed by your physician to see if the positive aspects of a medication out ways the negative effects.